BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Press Releases

  Radical™ Catheter Technologies Announces U.S. FDA 510(k) Clearance for its 6F Neurovascular Catheter -- Broadening Access Across a Wide Range of Applications

  April 14, 2026

   · 

  4 min read
• Press Releases

  Orum Therapeutics Appoints Dr. Maria Koehler and Geoff Meyerson to Board of Directors

  April 14, 2026

   · 

  5 min read
• Press Releases

  Protaryx Medical Receives FDA 510(k) Clearance for Its Breakthrough Transseptal Puncture Device

  April 14, 2026

   · 

  3 min read
• Press Releases

  Spyre Therapeutics Announces Proposed Public Offering of its Common Stock - April 13, 2026

  April 14, 2026

   · 

  6 min read
• Press Releases

  ImmuCell Bolsters its Innovation Strategy with Appointments of Dr. Gilles Guillemette and Dr. Anthony DiMarco to the Board, and Moves to a Smaller Board of Independent Directors

  April 14, 2026

   · 

  4 min read
• Press Releases

  Revolution Medicines, Inc. Announces Proposed Offerings of Common Stock and Convertible Senior Notes

  April 14, 2026

   · 

  6 min read
• Press Releases

  Hoth Therapeutics (HOTH) Reports Positive HT-VA CRADA Data: GDNF Reprograms Liver Fat Metabolism, Shuts Down Fat-Creation Gene and Activates Fat-Burning Pathways, Outperforming Semaglutide

  April 14, 2026

   · 

  6 min read
• Press Releases

  Kazia Therapeutics Expands Oncology Platform with First-in-Class SETDB1 Inhibitor Drug Development Platform

  April 14, 2026

   · 

  9 min read
• Press Releases

  Cema-Cel Pivotal Trial Interim Data Highlight Strength of Cellectis’ Allogeneic CAR-T Platform

  April 14, 2026

   · 

  6 min read
• Press Releases

  XORTX Announces Closing of Acquisition of Vectus Kidney Anti-fibrotic Asset

  April 14, 2026

   · 

  6 min read